| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
From the NMR Research Unit, Institute of Neurology, Queen Square, London, England.
The work of the NMR Research Group is made possible by a generous grant from the Multiple Sclerosis Society of Great Britain and Northern Ireland. JT is funded by the Medical Research Council. The spinal multi-array coil was kindly provided by GE Medical Systems.
Received November 22, 1994. Accepted in final form June 15, 1995.
Address correspondence to Dr Miller, NMR Research Unit, Institute of Neurology, Queen Square, London WCIN 3BG, England.
Although serial MRI studies of the brain in relapsing-remitting MS have demonstrated frequent asymptomatic disease activity, less is known about the spinal cord. We carried out monthly gadolinium-enhanced brain and spinal cord MRI scans over 1 year in 10 patients with relapsing-remitting MS. Six of the patients had a total of 11 clinical relapses, eight of which involved the spinal cord. A total of 167 active (enhancing or new nonenhancing) lesions in the brain and 19 in the spinal cord were present. Only one active brain lesion was symptomatic compared with six spinal cord lesions. Overall, one-third of new spinal cord lesions were symptomatic, and three-quarters of clinical spinal cord relapses were associated with a new MRI lesion in a location appropriate to the symptoms. Activity in both the spinal cord and brain was more common around the time of relapse. There was a strong association between the spinal cord and brain MRI activity. We did not detect progressive spinal cord atrophy from measurements of a spinal cord cross-sectional area. We conclude that, in relapsing-remitting MS, imaging of the brain alone will detect 90% of active lesions; spinal cord MRI using current technology will therefore provide only modest gains in treatment trials in which lesion activity is the primary outcome measure. The lack of progressive spinal cord atrophy in these patients, suggesting that significant axonal loss has not occurred, is in keeping with their good recovery after relapse. That brain and spinal cord lesions occur concurrently implies a systemic trigger for disease activity.
NEUROLOGY 1996;46: 373-378.
This article has been cited by other articles:
|
|
 |
|
  W Rashid, G R Davies, D T Chard, C M Griffin, D R Altmann, A J Thompson, and D H Miller Relationship of triple dose contrast enhanced lesions with clinical measures and brain atrophy in early relapsing-remitting multiple sclerosis: a two-year longitudinal study Multiple Sclerosis, March 1, 2007; 13(2): 178 - 185. [Abstract] [PDF]
|
|
|
|
 |
|
 X. Qi, A. S. Lewin, L. Sun, W. W. Hauswirth, and J. Guy Suppression of Mitochondrial Oxidative Stress Provides Long-term Neuroprotection in Experimental Optic Neuritis Invest. Ophthalmol. Vis. Sci., February 1, 2007; 48(2): 681 - 691. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. J. Hickman, A. T. Toosy, S. J. Jones, D. R. Altmann, K. A. Miszkiel, D. G. MacManus, G. J. Barker, G. T. Plant, A. J. Thompson, and D. H. Miller A serial MRI study following optic nerve mean area in acute optic neuritis Brain, November 1, 2004; 127(11): 2498 - 2505. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. C. J. Bot, E. L. A. Blezer, W. Kamphorst, G. J. Lycklama a Nijeholt, H. J. Ader, J. A. Castelijns, K. N. Ig, E. Bergers, R. Ravid, C. Polman, et al. The Spinal Cord in Multiple Sclerosis: Relationship of High-Spatial-Resolution Quantitative MR Imaging Findings to Histopathologic Results Radiology, November 1, 2004; 233(2): 531 - 540. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Rejdak, M. J. Eikelenboom, A. Petzold, E. J. Thompson, Z. Stelmasiak, R. H.C. Lazeron, F. Barkhof, C. H. Polman, B. M.J. Uitdehaag, and G. Giovannoni CSF nitric oxide metabolites are associated with activity and progression of multiple sclerosis Neurology, October 26, 2004; 63(8): 1439 - 1445. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 X Lin, C R Tench, B Turner, L D Blumhardt, and C S Constantinescu Spinal cord atrophy and disability in multiple sclerosis over four years: application of a reproducible automated technique in monitoring disease progression in a cohort of the interferon {beta}-1a (Rebif) treatment trial J. Neurol. Neurosurg. Psychiatry, August 1, 2003; 74(8): 1090 - 1094. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D J Mahad, J Lawry, S J. Howell, and M N Woodroofe Longitudinal study of chemokine receptor expression on peripheral lymphocytes in multiple sclerosis: CXCR3 upregulation is associated with relapse Multiple Sclerosis, April 1, 2003; 9(2): 189 - 198. [Abstract] [PDF]
|
|
|
|
|
|
F Sellebjerg, C V Jensen, H B. Larsson, and J L Frederiksen Gadolinium-enhanced magnetic resonance imaging predicts response to methylprednisolone in multiple sclerosis Multiple Sclerosis, February 1, 2003; 9(1): 102 - 107. [Abstract] [PDF]
|
|
|
|
 |
|
 J. S. Burks, B. G. Arnason, P. K. Coyle, C. C. Ford, A. Noronha, and K. W. Rammohan Issues and Practices in Multiple Sclerosis Neurorehabil Neural Repair, December 1, 2002; 16(4): 307 - 320. [Abstract] [PDF]
|
|
|
|
|
|
P. D. Molyneux, G. J. Barker, F. Barkhof, K. Beckmann, F. Dahlke, M. Filippi, M. Ghazi, D. Hahn, D. MacManus, C. Polman, et al. Clinical-MRI correlations in a European trial of interferon beta-1b in secondary progressive MS Neurology, December 26, 2001; 57(12): 2191 - 2197. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. J. L. a Nijeholt, E. Bergers, W. Kamphorst, J. Bot, K. Nicolay, J. A. Castelijns, J. H. T. M. van Waesberghe, R. Ravid, C. H. Polman, and F. Barkhof Post-mortem high-resolution MRI of the spinal cord in multiple sclerosis: A correlative study with conventional MRI, histopathology and clinical phenotype Brain, January 1, 2001; 124(1): 154 - 166. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Rovaris, M. Bozzali, G. Santuccio, G. Iannucci, M. P. Sormani, B. Colombo, G. Comi, and M. Filippi Relative contributions of brain and cervical cord pathology to multiple sclerosis disability: a study with magnetisation transfer ratio histogram analysis J. Neurol. Neurosurg. Psychiatry, December 1, 2000; 69(6): 723 - 727. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M Filippi Enhanced magnetic resonance imaging in multiple sclerosis Multiple Sclerosis, October 1, 2000; 6(5): 320 - 326. [Abstract] [PDF]
|
|
|
|
 |
|
 A. C. Scanderbeg, F. Tomaiuolo, U. Sabatini, U. Nocentini, M. G. Grasso, and C. Caltagirone Demyelinating Plaques in Relapsing-remitting and Secondary-progressive Multiple Sclerosis: Assessment with Diffusion MR Imaging AJNR Am. J. Neuroradiol., May 1, 2000; 21(5): 862 - 868. [Abstract] [Full Text]
|
|
|
|
|
|
M. A. Rocca, G. Mastronardo, M. A. Horsfield, C. Pereira, G. Iannucci, B. Colombo, L. Moiola, G. Comi, and M. Filippi Comparison of Three MR Sequences for the Detection of Cervical Cord Lesions in Patients with Multiple Sclerosis AJNR Am. J. Neuroradiol., October 1, 1999; 20(9): 1710 - 1716. [Abstract] [Full Text]
|
|
|
|
|
|
G. Mastronardo, M. A. Rocca, G. Iannucci, C. Pereira, and M. Filippi A Longitudinal MR Study of the Presymptomatic Phase in a Patient with Clinically Definite Multiple Sclerosis AJNR Am. J. Neuroradiol., August 1, 1999; 20(7): 1268 - 1272. [Abstract] [Full Text]
|
|
|
|
|
|
F. Fazekas, F. Barkhof, M. Filippi, R. I. Grossman, D. K. B. Li, W. I. McDonald, H. F. McFarland, D. W. Paty, J. H. Simon, J. S. Wolinsky, et al. The contribution of magnetic resonance imaging to the diagnosis of multiple sclerosis Neurology, August 1, 1999; 53(3): 448 - 448. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Liu, S. Edwards, Q. Gong, N. Roberts, and L. D Blumhardt Three dimensional MRI estimates of brain and spinal cord atrophy in multiple sclerosis J. Neurol. Neurosurg. Psychiatry, March 1, 1999; 66(3): 323 - 330. [Abstract] [Full Text]
|
|
|
|
|
|
M. Filippi, N. C Silver, T. A Yousry, and D. H Miller Newer magnetic resonance techniques and disease activity in multiple sclerosis: new concepts and new concerns Multiple Sclerosis, December 1, 1998; 4(6): 469 - 470. [PDF]
|
|
|
|
|
|
V. L. Stevenson, S. M. Leary, N. A. Losseff, G. J. M. Parker, G. J. Barker, Y. Husmani, D. H. Miller, and A. J. Thompson Spinal cord atrophy and disability in MS: A longitudinal study Neurology, July 1, 1998; 51(1): 234 - 238. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Schluep, G. van Melle, H. Henry, C. Stadler, B. Roth-Wicky, and P. J Magistretti In vitro cytokine profiles as indicators of relapse activity and clinical course in multiple sclerosis Multiple Sclerosis, June 1, 1998; 4(3): 198 - 202. [Abstract] [PDF]
|
|
|
|
|
|
G Giovannoni and E J Thompson Urinary markers of disease activity in multiple sclerosis Multiple Sclerosis, June 1, 1998; 4(3): 247 - 253. [Abstract] [PDF]
|
|
|
|
 |
|
 S. J. Khoury and H. L. Weiner Multiple Sclerosis: What Have We Learned From Magnetic Resonance Imaging Studies? Arch Intern Med, March 23, 1998; 158(6): 565 - 573. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N Tubridy, H J Ader, F Barkhof, A J Thompson, and D H Miller Exploratory treatment trials in multiple sclerosis using MRI: sample size calculations for relapsing-remitting and secondary progressive subgroups using placebo controlled parallel groups J. Neurol. Neurosurg. Psychiatry, January 1, 1998; 64(1): 50 - 55. [Abstract] [Full Text]
|
|
|
|
|
|
M. Filippi, F. Barkhof, S. Bressi, T. Yousry, and D. Miller Inter-rater variability in reporting enhancing lesions present on standard and triple dose gadolinium scans of patients with multiple sclerosis Multiple Sclerosis, August 1, 1997; 3(4): 226 - 230. [Abstract] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
